Stabilizing effect of tyrosine trimers on pDNA and siRNA polyplexes

Biomaterials

Volumn 34, Issue 5, 2013, Pages 1624-1633

  Troiber, Christina ^a   Edinger, Daniel ^a   Kos, Petra ^a   Schreiner, Laura ^a   Kläger, Raphaela ^a   Herrmann, Annika ^a   Wagner, Ernst ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Near infrared bioimaging; Plasmid DNA; Polyplexes; Serum stability; SiRNA

Indexed keywords

BIO-IMAGING; PLASMID DNA; POLYPLEXES; SERUM STABILITY; SIRNA;

AMINO ACIDS; BODY FLUIDS; PHENOLS;

OLIGOMERS;

CYSTEINE; OLIGOMER; PLASMID DNA; SMALL INTERFERING RNA; TYROSINE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG FORMULATION; FEMALE; FLUORESCENCE CORRELATION SPECTROSCOPY; GENE SILENCING; GENE TRANSFER; GENETIC TRANSFECTION; MOUSE; NEUROBLASTOMA; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL LINE, TUMOR; DIMERIZATION; DRUG STABILITY; MICE; NEUROBLASTOMA; PLASMIDS; RNA, SMALL INTERFERING; TRANSFECTION; TREATMENT OUTCOME; TYROSINE;

ANIMALIA; MUS;

EID: 84870725646     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.11.021     Document Type: Article

References (31)

1. Gao K., Huang L. Nonviral methods for siRNA delivery. Mol Pharm 2008, 6(3):651-658.
2. Miyata K., Nishiyama N., Kataoka K. Rational design of smart supramolecular assemblies for gene delivery: chemical challenges in the creation of artificial viruses. Chem Soc Rev 2012, 41(7):2562-2574.
3. Pack D.W., Hoffman A.S., Pun S., Stayton P.S. Design and development of polymers for gene delivery. Nat Rev Drug Discov 2005, 4(7):581-593.
4. Schaffert D., Wagner E. Gene therapy progress and prospects: synthetic polymer-based systems. Gene Ther 2008, 15(16):1131-1138.
5. Wagner E. Polymers for siRNA delivery: inspired by viruses to be targeted, dynamic, and precise. Acc Chem Res 2011, 45(7):1005-1013.
6. Boussif O., Lezoualc'h F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci 1995, 92(16):7297-7301.
7. Creusat G., Zuber G. Self-assembling polyethylenimine derivatives mediate efficient siRNA delivery in mammalian cells. Chembiochem 2008, 9(17):2787-2789.
8. Kwok A., Hart S.L. Comparative structural and functional studies of nanoparticle formulations for DNA and siRNA delivery. Nanomedicine 2011, 7(2):210-219.
9. Richards Grayson A., Doody A., Putnam D. Biophysical and structural characterization of polyethylenimine-mediated siRNA delivery in vitro. Pharm Res 2006, 23(8):1868-1876.
10. Tarcha P.J., Pelisek J., Merdan T., Waters J., Cheung K., von Gersdorff K., et al. Synthesis and characterization of chemically condensed oligoethylenimine containing beta-aminopropionamide linkages for siRNA delivery. Biomaterials 2007, 28(25):3731-3740.
11. Zintchenko A., Philipp A., Dehshahri A., Wagner E. Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity. Bioconjug Chem 2008, 19(7):1448-1455.
12. Creusat G., Rinaldi A.-S., Weiss E., Elbaghdadi R., Remy J.-S., Mulherkar R., et al. Proton sponge trick for pH-Sensitive disassembly of polyethylenimine-based siRNA delivery systems. Bioconjug Chem 2010, 21(5):994-1002.
13. Zaghloul E.M., Viola J.R., Zuber G., Smith C.I.E., Lundin K.E. Formulation and delivery of splice-correction antisense oligonucleotides by amino acid modified polyethylenimine. Mol Pharm 2010, 7(3):652-663.
14. Hunter C.A., Sanders J.K.M. The nature of π-π interactions. J Am Chem Soc 1990, 112(14):5525-5534.
15. Zaupa A., Neffe A.T., Pierce B.F., Nöchel U., Lendlein A. Influence of tyrosine-derived moieties and drying conditions on the formation of helices in gelatin. Biomacromolecules 2010, 12(1):75-81.
16. Soo Choi H., Liu W., Misra P., Tanaka E., Zimmer J.P., Itty Ipe B., et al. Renal clearance of quantum dots. Nat Biotechnol 2007, 25(10):1165-1170.
17. Heidel J., Davis M. Clinical developments in nanotechnology for cancer therapy. Pharm Res 2011, 28(2):187-199.
18. Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzym Regul 2001, 41(1):189-207.
19. Nomura T., Koreeda N., Yamashita F., Takakura Y., Hashida M. Effect of particle size and charge on the disposition of lipid carriers after intratumoral injection into tissue-isolated tumors. Pharm Res 1998, 15(1):128-132.
20. Fröhlich T., Edinger D., Kläger R., Troiber C., Salcher E., Badgujar N., et al. Structure-activity relationships of siRNA carriers based on sequence-defined oligo (ethane amino) amides. J Control Release 2012, 160(3):532-541.
21. Schaffert D., Troiber C., Salcher E.E., Fröhlich T., Martin I., Badgujar N., et al. Solid-phase synthesis of sequence-defined T-, i-, and U-shape polymers for pDNA and siRNA delivery. Angew Chem Int Ed 2011, 50(38):8986-8989.
22. Schaffert D., Troiber C., Wagner E. New sequence-defined polyaminoamides with tailored endosomolytic properties for plasmid DNA delivery. Bioconjug Chem 2012, 23(6):1157-1165.
23. Salcher EE, Kos P, Fröhlich T, Badgujar N, Scheible M, Wagner E. Sequencedefined four-arm oligo(ethanamino)amides for pDNA and siRNA delivery: impact of building blocks on efficacy. J Control Release http://dx.doi.org/10.1016/j.jconrel.2012.06.023.
24. Remaut K., Lucas B., Raemdonck K., Braeckmans K., Demeester J., De Smedt S.C. Can we better understand the intracellular behavior of DNA nanoparticles by fluorescence correlation spectroscopy?. J Control Release 2007, 121(1-2):49-63.
25. Troiber C, Kasper JC, Milani S, Scheible M, Martin I, Schaubhut F, et al. Comparison of four different particle sizing methods for siRNA polyplex characterization. Eur J Pharm Biopharm. doi:10.1016/j.ejpb.2012.08.014.
26. Buyens K., Lucas B., Raemdonck K., Braeckmans K., Vercammen J., Hendrix J., et al. A fast and sensitive method for measuring the integrity of siRNA-carrier complexes in full human serum. J Control Release 2008, 126(1):67-76.
27. Buyens K., Meyer M., Wagner E., Demeester J., De Smedt S.C., Sanders N.N. Monitoring the disassembly of siRNA polyplexes in serum is crucial for predicting their biological efficacy. J Control Release 2010, 141(1):38-41.
28. Dohmen C., Edinger D., Fröhlich T., Schreiner L., Lächelt U., Troiber C., et al. Nanosized multifunctional polyplexes for receptor-mediated siRNA delivery. ACS Nano 2012, 6(6):5198-5208.
29. Huang Y., Hong J., Zheng S., Ding Y., Guo S., Zhang H., et al. Elimination pathways of systemically delivered siRNA. Mol Ther 2011, 19(2):381-385.
30. Zhang Y., Bradshaw-Pierce E.L., DeLille A., Gustafson D.L., Anchordoquy T.J. In vivo comparative study of lipid/DNA complexes with different in vitro serum stability: effects on biodistribution and tumor accumulation. J Pharm Sci 2008, 97(1):237-250.
31. Tietze N., Pelisek J., Philipp A., Roedl W., Merdan T., Tarcha P., et al. Induction of apoptosis in murine neuroblastoma by systemic delivery of transferrin-shielded siRNA polyplexes for downregulation of Ran. Oligonucleotides 2008, 18(2):161-174.